Trials / Completed
CompletedNCT03341117
Acetylsalicylic Acid and Type 2 Diabetes Mellitus
Acetylsalicylic Acid Administered in Patients With Type 2 Diabetes Mellitus and Its Effect on the Antioxidant Enzyme System
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Centro Universitario de Ciencias de la Salud, Mexico · Academic / Other
- Sex
- All
- Age
- 35 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
OBJETIVE To assess the effect of acetylsalicylic acid on antioxidant enzymatic system in patients with type 2 diabetes
Detailed description
A randomized, double blind placebo controlled clinical trial was carried out in 21 adult patients with type 2 diabetes. Acetylsalicylic acid 300mg/d was administered orally for 3 months to study group (n=11) and placebo to the control group (n=10).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acetylsalicylic acid | Acetylsalicylic acid 300 mg per capsule |
| DRUG | Calcined magnesia | Calcined magnesia 300 mg per capsule |
Timeline
- Start date
- 2014-12-02
- Primary completion
- 2015-12-02
- Completion
- 2016-12-02
- First posted
- 2017-11-14
- Last updated
- 2017-11-14
Source: ClinicalTrials.gov record NCT03341117. Inclusion in this directory is not an endorsement.